Dr. Benjamin M. Greenberg, member of SRNA’s Board of Directors and SRNA’s Medical and Scientific Council, discussed COVID-19 vaccinations and the implications for those with rare neuroimmune disorders.
Part I: [ Ссылка ]
Part III: [ Ссылка ]
Part IV: [ Ссылка ]
COVID-19 Vaccines Part II with Dr. Greenberg
Теги
covidcovid19covid-19covid vaccinescovid vaccinecovid-19 vaccinecovid-19 vaccinescoronaviruscoronavirus vaccinesrare neuroimmune disordersAFMacute flaccid myelitisADEMacute disseminated encephalomyelitisMOGADMOG antibody disesaeMOGMOG diseaseneuromyelitis opticaneuromyelitis optica spectrum disorderNMONMOSDoptic neuritisONtransverse myelitisTMmyelitismyelitis vaccinesmyelitis vaccine
